The Conversation (0)
Aurora Cannabis and Radient Technologies completed their joint research into whether Radient’s proprietary MAP technology and an “associated continuous flow design” extracting cannabinoids.
Aurora Cannabis (TSXV:ACB; OTCQX:ACBFF; FRANKFURT:21P) and Radient Technologies (TSXV:RTI) completed their joint research into Radient’s proprietary MAP technology and an “associated continuous flow design” extracting cannabinoids.
As quoted in the press release:
The first element of the collaboration was the execution of a joint research project to assess the feasibility of applying Radient’s proprietary technology for the extraction of cannabinoids from cannabis, including the establishment of parameters of extraction yields, recovery rates of available cannabinoids, purity of the extracts obtained, and the determination of cannabinoids and terpene profiles. The feasibility study also included an assessment of the potential processing throughput achievable using Radient’s large-scale continuous-flow MAP™ extractor, based upon established extraction conditions.
Radient’s MAP™ technology enables precise control of temperature and extraction time of continuously flowing material, both of which affect purity and extract profile. This careful control of extraction parameters and product quality is something that is impossible to achieve at large scale using conventional methods. Extremely high (quantitative) recovery of available cannabinoids is possible in extraction times that are shaved from hours to minutes.
The study was conducted in two phases: bench-scale screening experiments of MAP™ extraction conditions; and scaled-up experiments under preferred extraction conditions. The analytical data from the research project were verified and confirmed by Anandia Labs Inc., a leading Canadian independent cannabis testing laboratory.
Click here to read the full press release.
Source: www.marketwired.com
